Company / Capital Expenditures
Dynavax Technologies Corp. Capital Expenditures History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$6.4M
FY2024
5-year range
$4.1M / $9.5M
FY2020-FY2024
Trend
+54.8%
vs FY2023
Sector context
#67 of 192
Health Care
What the data says
At $6M, Dynavax Technologies Corp.'s capital expenditures ranks #67 of 192 in the Health Care sector. Capital Expenditures returned to growth in FY2024 after 2 years of decline, reaching $6M.
Based on SEC 10-K filings.
$6M in FY2024 with a 5-year CAGR of -22.3%.
Declined from $7M to $6M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -12.5%
- 5-Year CAGR
- -22.3%
- 10-Year CAGR
- -
Sector benchmark
#67 of 192 in Health CareTop 35% of 192This company $6.4M Sector average $118.6M
▼
-94.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -22.3%, indicating a declining trend.
- In FY2024, capital expenditures increased 54.8% year-over-year.
- Ranks #67 out of 192 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.4M | +54.8% |
| FY2023 | $4.1M | -42.5% |
| FY2022 | $7.1M | -24.7% |
| FY2021 | $9.5M | +132.7% |
| FY2020 | $4.1M | -81.8% |
| FY2019 | $22.4M | +435.0% |
| FY2018 | $4.2M | +525.9% |
| FY2017 | $669.0K | -91.4% |
| FY2016 | $7.8M | +11.3% |
| FY2015 | $7.0M | +318.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026